As researchers discover more genetic links to diseases, newer and more accurate diagnostic and screening tests are making their way to the market. But with an increasing array of tests out there, it is becoming more difficult for providers to determine which screening and diagnostic tests will offer tangible benefits to patients and which will most likely cost them and their insurers vast amounts of money and raise more questions than answers.
As researchers discover more genetic links to diseases, newer and more accurate diagnostic and screening tests are making their way to the market. But with an increasing array of tests out there, it is becoming more difficult for providers to determine which screening and diagnostic tests will offer tangible benefits to patients and which will most likely cost them and their insurers vast amounts of money and raise more questions than answers.
Availability of prenatal genetic tests questioned
September 1, 2004